Search - tctmd.com

Displaying 301 - 320 of 367

Sort: Relevancy | Date

News Features

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Michael O'Riordan

March 23, 2018

News Conference News ACC 2018

Perioperative Beta-blockade for Noncardiac Surgery Increases Death, Stroke at 1 Year

Yael L. Maxwell

March 15, 2018

News Conference News ACC 2018

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

Caitlin E. Cox

March 14, 2018

News Conference News ACC 2018

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Shelley Wood

March 10, 2018

News Daily News

Less Aggressive HbA1c Targets Recommended by American College of Physicians

Michael O'Riordan

March 06, 2018

News Daily News

Roughly Half of Obese Patients Who Have Bariatric Surgery Are Off Type 2 Diabetes Meds at 6 Years

Michael O'Riordan

February 19, 2018

News Daily News

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

Michael O'Riordan

January 24, 2018

News Daily News

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Caitlin E. Cox

January 18, 2018

News Daily News

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Michael O'Riordan

January 09, 2018

News Daily News

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

Caitlin E. Cox

January 08, 2018

News Daily News

Coronary CTA in the ED for Chest Pain Ups Statins, Aspirin on Discharge in Those at Highest Risk

Yael L. Maxwell

December 12, 2017

News Daily News

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

Caitlin E. Cox

December 12, 2017

News Daily News

Some Concerns About New ‘Tour de Force’ Hypertension Guidelines

Todd Neale

December 04, 2017

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Conference News AHA 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Michael O'Riordan

November 17, 2017

News Daily News

Statins and Diabetes: Causal Link Reinforced in New Analysis

Michael O'Riordan

October 25, 2017

News Daily News

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Michael O'Riordan

October 19, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Daily News

Popular CV Risk Calculator Is Not Accurate Among Patients at Low Socioeconomic Standing

Yael L. Maxwell

August 31, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

Advertisement

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Perioperative Beta-blockade for Noncardiac Surgery Increases Death, Stroke at 1 Year

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Less Aggressive HbA1c Targets Recommended by American College of Physicians

Roughly Half of Obese Patients Who Have Bariatric Surgery Are Off Type 2 Diabetes Meds at 6 Years

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

Coronary CTA in the ED for Chest Pain Ups Statins, Aspirin on Discharge in Those at Highest Risk

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

Some Concerns About New ‘Tour de Force’ Hypertension Guidelines

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Statins and Diabetes: Causal Link Reinforced in New Analysis

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

New Performance and Quality Metrics for STEMI and NSTEMI Care

Popular CV Risk Calculator Is Not Accurate Among Patients at Low Socioeconomic Standing

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content